Depression
Showing NaN - NaN of 20
Cancer, Bone Marrow Tumors, Anxiety Trial in United States (PRISM (Promoting Resilience in Stress Management))
Active, not recruiting
- Cancer
- +7 more
- PRISM (Promoting Resilience in Stress Management)
-
Birmingham, Alabama
- +4 more
Nov 29, 2022
MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)
Completed
- Major Depressive Disorder
- +2 more
- AXS-05 (dextromethorphan and bupropion) oral tablets
-
Phoenix, Arizona
- +50 more
Sep 16, 2022
Violence, Depression, PTSD Trial in Notre Dame, Memphis (Pregnant Moms' Empowerment Program)
Completed
- Violence
- +5 more
- Pregnant Moms' Empowerment Program
-
Notre Dame, Indiana
- +1 more
Sep 26, 2022
Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Phoenix, Arizona
- +42 more
Sep 22, 2021
Aspirin in Reducing Events in the Elderly
Active, not recruiting
- Functional Disability
- +6 more
- 100 mg enteric-coated aspirin
- Placebo
-
Birmingham, Alabama
- +46 more
Apr 2, 2021
HIV, Depression Trial in United States (Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management
Completed
- HIV
- Depression
- Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management Algorithm
- Enhanced Standard of Care
-
Alhambra, California
- +12 more
Mar 2, 2021
Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Depression
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Beverly Hills, California
- +34 more
Dec 23, 2019
Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)
Completed
- Bipolar Disorder
- Depression
- Cariprazine
- Placebo
-
Little Rock, Arkansas
- +73 more
Jan 10, 2019
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712, Escitalopram, Fluoxetine)
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (Placebo + ADT, Brexpiprazole +ADT)
Completed
- Depressive Disorder
- +4 more
- Placebo + ADT
- Brexpiprazole +ADT
-
Birmingham, Alabama
- +46 more
Aug 17, 2018
HIV, Depression, HIV Trial in United States (COMB - Combination Cognitive Behavioral Therapy and Medication Management, TAU -
Completed
- HIV
- +2 more
- COMB - Combination Cognitive Behavioral Therapy and Medication Management
- TAU - Treatment as Usual
-
Tampa, Florida
- +3 more
Feb 27, 2017
Sexual Dysfunctions, Psychological, Depression Trial in United States (flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs,
Terminated
- Sexual Dysfunctions, Psychological
- Depression
- flibanserin 50 mg to 100 mg qhs
- +2 more
-
Costa Mesa, California
- +41 more
Jul 14, 2016
Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)
Completed
- Depressive Disorder
- +4 more
- OPC-34712 + ADT
- Placebo + ADT
-
Birmingham, Alabama
- +70 more
Nov 30, 2015
Depression Trial in Worldwide (Placebo matching with BMS-820836, BMS-820836)
Terminated
- Depression
- Placebo matching with BMS-820836
- BMS-820836
-
Birmingham, Alabama
- +143 more
Sep 23, 2015
MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- Depression
- TC-5214
- Placebo
-
Birmingham, Alabama
- +98 more
Mar 14, 2014
Parkinson Disease, Depression Trial in Canada, Puerto Rico, United States (paroxetine, venlafaxine, )
Completed
- Parkinson Disease
- Depression
- paroxetine
- +2 more
-
San Francisco, California
- +17 more
Jan 3, 2013
Depression Trial in United States (blood draw)
Completed
- Depression
- blood draw
-
Birmingham, Alabama
- +52 more
Jan 5, 2011
Depression, Depressive Disorder, Depressive Disorder, Major Trial in Worldwide (Desvenlafaxine succinate sustained-release (DVS
Completed
- Depression
- +2 more
- Desvenlafaxine succinate sustained-release (DVS SR)
- Escitalopram
-
Peoria, Arizona
- +69 more
May 26, 2010